Clinical trial
Efficacy and Safety of Low-Dose Tenecteplase for Acute Ischemic Stroke Treatment in Aging Patients: A Prospective, Multicenter, Randomized Controlled Study
NCT07294209 is registered in ClinicalTrials.gov with Southwest Hospital, China as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Low-Dose Tenecteplase for Acute Ischemic Stroke Treatment in Aging Patients: A Prospective, Multicenter, Randomized Controlled Study
- Lead sponsor
- Southwest Hospital, China
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- December 19, 2025
- Completion date
- December 31, 2028
- Enrollment
- 798 (estimated)
- Sites
- 51
Conditions
As the registry lists them; a condition with its own page is linked.
acute ischemic stroke patients